Blood Clot clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages up to 17 years
To assess the safety and descriptive efficacy of apixaban in pediatric subjects requiring anticoagulation for the treatment of a VTE.
at UC Davis UCSF